Abiopharma

ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

Best iRobot Robot Vacuum Models for Home Cleaning in 2025

Indiana Jones and the Great Circle: What’s Next for the Hit Adventure Game?

Microsoft Is Ditching Passwords: What You Need to Know About the Shift to Passkeys

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC

NEOG BREAKING NEWS: A Securities Fraud Class Action has been filed against Neogen Corporation -- Investors are Notified to Contact BFA Law to Potentially Recover Investment Losses

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study

Merck Announces Fourth-Quarter 2025 Dividend

Rosen Law Firm Urges Alto Neuroscience, Inc. (NYSE: ANRO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Rosen Law Firm Encourages Replimune Group, Inc. Investors to Inquire About Securities Class Action Investigation – REPL